 |
 |

Decreased Response to Phototherapy for Neonatal Jaundice in Breast-fed Infants
K. L. Tan, FRCPE, FRACP, DCH
Arch Pediatr Adolesc Med. 1998;152:1187-1190.
Objective To evaluate the efficacy of phototherapy for nonhemolytic hyperbilirubinemia in breast-fed and formula-fed infants and infants receiving formula and breast milk.
Design Prospective study.
Setting Nursery for healthy infants.
Method Full-term healthy infants with nonhemolytic hyperbilirubinemia (bilirubin concentration, >255 µmol/L [14.9 mg/dL] or 222 µmol/L [13.0 mg/dL] at ages younger than 48 hours) were treated with conventional phototherapy by using daylight fluorescent lamps. Three groups of infants were studied: group 1, formula-fed infants; group 2, breast-fed infants; and group 3, infants receiving formula and breast milk. All patterns of feeding started at birth. Phototherapy was terminated only when bilirubin concentrations had decreased to less than 185 µmol/L (10.8 mg/dL); the minimum exposure period was 24 hours.
Results A total of 163 infants were studied: group 1, 79; group 2, 34; and group 3, 50. The age at the start of exposure was comparable in all groups. The mean±SD weight loss as a percentage of birth weight was as follows: group 1, 2.8%±5.0%; group 2, 6.1%±3.4%; and group 3, 3.2%±2.6%. The duration of exposure to phototherapy was as follows: group 1, 54.1±20.8 hours; group 2, 64.6±25.1 hours; and group 3, 54.9±21.5 hours; the 24-hour rate of decrease in the bilirubin concentration was as follows: group 1, 18.6%±11.7%; group 2, 17.1%±9.6%; and group 3, 22.9%±9.4%. The overall rate of decrease in the bilirubin concentration for the duration of exposure to phototherapy was as follows: group 1, 0.8%±0.3% per hour; group 2, 0.6%±0.3% per hour; and group 3, 0.8%±0.3% per hour. Weight loss at the start of phototherapy was significantly greater in group 2 compared with group 1 (P<.001) and group 3 (P<.001), although the hemoglobin and hematocrit values were comparable. The duration of exposure to phototherapy was not significantly different in the 3 groups (P=.06); however, the duration of exposure of group 2 infants was 10 hours more than that of the other 2 groups. The 24-hour rate of decrease in the bilirubin concentration in group 3 was significantly better than that of group 2 (P=.007) and group 3 (P=.02); the rates of decrease for groups 2 and 3 were similar (P=.52). The overall rate of decrease in the bilirubin concentration during the duration of exposure to phototherapy in group 2 was significantly less than that of group 1 (P=.002) and group 3 (P<.001); the rates for groups 1 and 3 were similar (P=.35). The postexposure rebound bilirubin concentrations were comparable in all groups during the first 2 days; however, the duration of moderate jaundice in group 2 was more prolonged.
Conclusions The response to phototherapy of group 2 infants was significantly slower than that of group 3 and group 1 infants; this response was still of adequate efficacy. The addition of formula to the feedings for totally breast-fed infants, without suspension of breast-feeding, would enhance the efficacy of phototherapy and reduce exposure time.
From the Department of Neonatology, National University Hospital, Singapore, Republic of Singapore.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Neonatal Hyperbilirubinemia
Dennery et al.
NEJM 2001;344:581-590.
FULL TEXT
Recent Developments in the Management of Neonatal Hyperbilirubinemia
Hammerman and Kaplan
NeoReviews 2000;1:e19-24.
FULL TEXT
Breastfeeding, Diet, and Neonatal Hyperbilirubinemia
Gourley
NeoReviews 2000;1:e25-31.
FULL TEXT
Nutrition and Jaundice: Hold the Bottle, Keep the Breast
Hertz et al.
Arch Pediatr Adolesc Med 1999;153:1002-1003.
FULL TEXT
Supplemental Breast Milk Is the Best Milk
Hertz and Tan
Arch Pediatr Adolesc Med 1999;153:655-656.
FULL TEXT
Breast-feeding, Jaundice, and Formula
Newman and Tan
Arch Pediatr Adolesc Med 1999;153:656-657.
FULL TEXT
Formula for Jaundiced Breast-fed Infants
Watkinson
Arch Pediatr Adolesc Med 1999;153:657-658.
FULL TEXT
|